Cite
Shulman DS, Kiwinda LV, Edwards S, et al. Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncology. Cancer Med. 2021;doi: 10.1002/cam4.3791.
Shulman, D. S., Kiwinda, L. V., Edwards, S., Clinton, C. M., Hunt, S., Greenspan, L., Lawler, K. D., Reaman, G., Al-Sayegh, H., Bona, K., O'Neill, A. F., Shusterman, S., Janeway, K. A., Place, A. E., Chi, S. N., Ma, C., & DuBois, S. G. (2021). Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncology. Cancer medicine, . https://doi.org/10.1002/cam4.3791
Shulman, David S, et al. "Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncology." Cancer medicine vol. (2021). doi: https://doi.org/10.1002/cam4.3791
Shulman DS, Kiwinda LV, Edwards S, Clinton CM, Hunt S, Greenspan L, Lawler KD, Reaman G, Al-Sayegh H, Bona K, O'Neill AF, Shusterman S, Janeway KA, Place AE, Chi SN, Ma C, DuBois SG. Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncology. Cancer Med. 2021 Mar 09; doi: 10.1002/cam4.3791. Epub 2021 Mar 09. PMID: 33751835; PMCID: PMC7982629.
Copy
Download .nbib